US Stock MarketDetailed Quotes

AVDL Avadel Pharmaceuticals

Watchlist
  • 10.320
  • +0.320+3.20%
Close Dec 11 16:00 ET
  • 10.640
  • +0.320+3.10%
Pre 05:24 ET
994.45MMarket Cap-13.76P/E (TTM)

Avadel Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
81.98%-6.89M
43.21%-18.19M
1.75%-29.7M
-82.79%-128.51M
-82.41%-28.03M
-461.90%-38.23M
-127.27%-32.02M
11.20%-30.23M
9.06%-70.3M
31.72%-15.37M
Net income from continuing operations
92.76%-2.63M
78.55%-13.82M
11.18%-27.34M
-16.59%-160.28M
-4.87%-28.79M
-80.06%-36.27M
-1.56%-64.43M
-16.50%-30.78M
-77.77%-137.46M
-23.09%-27.45M
Operating gains losses
----
----
----
--13.13M
--0
--0
----
----
----
----
Depreciation and amortization
73.95%1.04M
-27.29%437K
-7.99%541K
18.29%1.77M
-103.07%-18K
48.38%595K
143.32%601K
127.03%588K
83.19%1.49M
191.54%586K
Deferred tax
----
----
----
--0
----
----
----
----
266.12%26.03M
102.51%109K
Other non cash items
383.64%156K
-177.62%-489K
-138.41%-719K
-49.86%4.06M
-34.00%1.61M
-102.48%-55K
-74.33%630K
90.83%1.87M
251.45%8.09M
412.82%2.44M
Change In working capital
-93.38%-10.87M
-193.94%-9.77M
-120.72%-7.57M
-112.22%-3M
-162.01%-4.35M
-164.18%-5.62M
-34.15%10.41M
51.28%-3.43M
564.01%24.54M
935.55%7.02M
-Change in receivables
36.64%-4.18M
-3,002.56%-10.22M
---10.61M
-34,163.33%-10.22M
-132,766.67%-3.98M
-219,600.00%-6.59M
618.37%352K
--0
-98.93%30K
101.06%3K
-Change in inventory
22.25%-2.99M
30.23%-1M
---1.26M
---9.53M
---4.25M
---3.85M
---1.44M
--0
--0
--0
-Change in prepaid assets
-104.85%-58K
1,786.25%4.54M
-47.49%-6.09M
-110.15%-3.13M
-97.35%76K
-91.83%1.2M
-101.75%-269K
-100.73%-4.13M
7,119.36%30.82M
844.68%2.87M
-Change in payables and accrued expense
-196.56%-1.68M
-126.03%-3.1M
1,241.05%10.94M
739.95%18.44M
-11.00%3.98M
131.94%1.74M
749.39%11.9M
124.73%816K
-156.19%-2.88M
53.80%4.47M
-Change in other working capital
-204.20%-1.96M
105.76%8K
-380.17%-557K
142.05%1.44M
42.81%-183K
536.19%1.88M
86.25%-139K
93.04%-116K
9.50%-3.43M
79.50%-320K
Cash from discontinued investing activities
Operating cash flow
81.98%-6.89M
43.21%-18.19M
1.75%-29.7M
-82.79%-128.51M
-82.41%-28.03M
-461.90%-38.23M
-127.27%-32.02M
11.20%-30.23M
9.06%-70.3M
31.72%-15.37M
Investing cash flow
Cash flow from continuing investing activities
-49.80%4.93M
111.36%10.55M
322.17%21.39M
-162.85%-50.09M
22.09%27.93M
289.10%9.82M
-871.15%-92.91M
-88.01%5.07M
40.00%79.7M
49.31%22.88M
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
-2,653.85%-716K
--0
Net business purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Net investment purchase and sale
-49.80%4.93M
111.36%10.55M
322.17%21.39M
-162.29%-50.09M
22.09%27.93M
203.12%9.82M
-871.15%-92.91M
-88.01%5.07M
98.77%80.41M
49.31%22.88M
Cash from discontinued investing activities
Investing cash flow
-49.80%4.93M
111.36%10.55M
322.17%21.39M
-162.85%-50.09M
22.09%27.93M
289.10%9.82M
-871.15%-92.91M
-88.01%5.07M
40.00%79.7M
49.31%22.88M
Financing cash flow
Cash flow from continuing financing activities
-96.14%1.18M
-99.21%723K
-61.70%13.19M
830.59%135.34M
-418.80%-21.11M
184.27%30.46M
2,005.98%91.54M
1,614.39%34.44M
5,429.66%14.54M
6.62M
Net issuance payments of debt
--0
--0
--0
---21.17M
---3.67M
--0
--0
---17.5M
--0
--0
Net common stock issuance
--0
--0
-22.35%9.25M
476.92%146.06M
-99.99%2K
-100.02%-2K
--134.15M
--11.91M
--25.32M
--14.79M
Net preferred stock issuance
----
----
--0
----
----
----
----
--40M
----
----
Proceeds from stock option exercised by employees
154.76%1.18M
-58.69%723K
13,486.21%3.94M
-14.50%2.29M
-89.39%52K
152.46%462K
--1.75M
-98.56%29K
919.77%2.68M
--490K
Net other financing activities
----
----
----
160.51%8.14M
-102.22%-17.5M
--30M
----
----
---13.46M
---8.65M
Cash from discontinued financing activities
Financing cash flow
-96.14%1.18M
-99.21%723K
-61.70%13.19M
830.59%135.34M
-418.80%-21.11M
184.27%30.46M
2,005.98%91.54M
1,614.39%34.44M
5,429.66%14.54M
--6.62M
Net cash flow
Beginning cash position
-42.29%28.85M
-57.08%35.79M
-57.87%31.17M
45.90%73.98M
-14.67%51.81M
-7.65%49.99M
36.99%83.39M
45.90%73.98M
-29.30%50.71M
4.38%60.72M
Current changes in cash
-138.10%-783K
79.29%-6.91M
-47.46%4.87M
-280.76%-43.27M
-250.11%-21.21M
-68.07%2.06M
-387.76%-33.39M
-9.20%9.28M
218.98%23.94M
296.65%14.13M
Effect of exchange rate changes
326.20%518K
-78.95%-34K
-282.22%-246K
168.52%455K
165.66%568K
-251.66%-229K
-119.00%-19K
370.00%135K
25.89%-664K
-214.55%-865K
End cash Position
-44.83%28.58M
-42.29%28.85M
-57.08%35.79M
-57.87%31.17M
-57.87%31.17M
-14.67%51.81M
-7.65%49.99M
36.99%83.39M
45.90%73.98M
45.90%73.98M
Free cash flow
81.98%-6.89M
43.21%-18.19M
1.75%-29.7M
-80.95%-128.51M
-82.41%-28.03M
-408.39%-38.23M
-127.27%-32.02M
11.20%-30.23M
8.17%-71.02M
31.72%-15.37M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 81.98%-6.89M43.21%-18.19M1.75%-29.7M-82.79%-128.51M-82.41%-28.03M-461.90%-38.23M-127.27%-32.02M11.20%-30.23M9.06%-70.3M31.72%-15.37M
Net income from continuing operations 92.76%-2.63M78.55%-13.82M11.18%-27.34M-16.59%-160.28M-4.87%-28.79M-80.06%-36.27M-1.56%-64.43M-16.50%-30.78M-77.77%-137.46M-23.09%-27.45M
Operating gains losses --------------13.13M--0--0----------------
Depreciation and amortization 73.95%1.04M-27.29%437K-7.99%541K18.29%1.77M-103.07%-18K48.38%595K143.32%601K127.03%588K83.19%1.49M191.54%586K
Deferred tax --------------0----------------266.12%26.03M102.51%109K
Other non cash items 383.64%156K-177.62%-489K-138.41%-719K-49.86%4.06M-34.00%1.61M-102.48%-55K-74.33%630K90.83%1.87M251.45%8.09M412.82%2.44M
Change In working capital -93.38%-10.87M-193.94%-9.77M-120.72%-7.57M-112.22%-3M-162.01%-4.35M-164.18%-5.62M-34.15%10.41M51.28%-3.43M564.01%24.54M935.55%7.02M
-Change in receivables 36.64%-4.18M-3,002.56%-10.22M---10.61M-34,163.33%-10.22M-132,766.67%-3.98M-219,600.00%-6.59M618.37%352K--0-98.93%30K101.06%3K
-Change in inventory 22.25%-2.99M30.23%-1M---1.26M---9.53M---4.25M---3.85M---1.44M--0--0--0
-Change in prepaid assets -104.85%-58K1,786.25%4.54M-47.49%-6.09M-110.15%-3.13M-97.35%76K-91.83%1.2M-101.75%-269K-100.73%-4.13M7,119.36%30.82M844.68%2.87M
-Change in payables and accrued expense -196.56%-1.68M-126.03%-3.1M1,241.05%10.94M739.95%18.44M-11.00%3.98M131.94%1.74M749.39%11.9M124.73%816K-156.19%-2.88M53.80%4.47M
-Change in other working capital -204.20%-1.96M105.76%8K-380.17%-557K142.05%1.44M42.81%-183K536.19%1.88M86.25%-139K93.04%-116K9.50%-3.43M79.50%-320K
Cash from discontinued investing activities
Operating cash flow 81.98%-6.89M43.21%-18.19M1.75%-29.7M-82.79%-128.51M-82.41%-28.03M-461.90%-38.23M-127.27%-32.02M11.20%-30.23M9.06%-70.3M31.72%-15.37M
Investing cash flow
Cash flow from continuing investing activities -49.80%4.93M111.36%10.55M322.17%21.39M-162.85%-50.09M22.09%27.93M289.10%9.82M-871.15%-92.91M-88.01%5.07M40.00%79.7M49.31%22.88M
Net PPE purchase and sale --------------0-----------------2,653.85%-716K--0
Net business purchase and sale --------------0------------------0----
Net investment purchase and sale -49.80%4.93M111.36%10.55M322.17%21.39M-162.29%-50.09M22.09%27.93M203.12%9.82M-871.15%-92.91M-88.01%5.07M98.77%80.41M49.31%22.88M
Cash from discontinued investing activities
Investing cash flow -49.80%4.93M111.36%10.55M322.17%21.39M-162.85%-50.09M22.09%27.93M289.10%9.82M-871.15%-92.91M-88.01%5.07M40.00%79.7M49.31%22.88M
Financing cash flow
Cash flow from continuing financing activities -96.14%1.18M-99.21%723K-61.70%13.19M830.59%135.34M-418.80%-21.11M184.27%30.46M2,005.98%91.54M1,614.39%34.44M5,429.66%14.54M6.62M
Net issuance payments of debt --0--0--0---21.17M---3.67M--0--0---17.5M--0--0
Net common stock issuance --0--0-22.35%9.25M476.92%146.06M-99.99%2K-100.02%-2K--134.15M--11.91M--25.32M--14.79M
Net preferred stock issuance ----------0------------------40M--------
Proceeds from stock option exercised by employees 154.76%1.18M-58.69%723K13,486.21%3.94M-14.50%2.29M-89.39%52K152.46%462K--1.75M-98.56%29K919.77%2.68M--490K
Net other financing activities ------------160.51%8.14M-102.22%-17.5M--30M-----------13.46M---8.65M
Cash from discontinued financing activities
Financing cash flow -96.14%1.18M-99.21%723K-61.70%13.19M830.59%135.34M-418.80%-21.11M184.27%30.46M2,005.98%91.54M1,614.39%34.44M5,429.66%14.54M--6.62M
Net cash flow
Beginning cash position -42.29%28.85M-57.08%35.79M-57.87%31.17M45.90%73.98M-14.67%51.81M-7.65%49.99M36.99%83.39M45.90%73.98M-29.30%50.71M4.38%60.72M
Current changes in cash -138.10%-783K79.29%-6.91M-47.46%4.87M-280.76%-43.27M-250.11%-21.21M-68.07%2.06M-387.76%-33.39M-9.20%9.28M218.98%23.94M296.65%14.13M
Effect of exchange rate changes 326.20%518K-78.95%-34K-282.22%-246K168.52%455K165.66%568K-251.66%-229K-119.00%-19K370.00%135K25.89%-664K-214.55%-865K
End cash Position -44.83%28.58M-42.29%28.85M-57.08%35.79M-57.87%31.17M-57.87%31.17M-14.67%51.81M-7.65%49.99M36.99%83.39M45.90%73.98M45.90%73.98M
Free cash flow 81.98%-6.89M43.21%-18.19M1.75%-29.7M-80.95%-128.51M-82.41%-28.03M-408.39%-38.23M-127.27%-32.02M11.20%-30.23M8.17%-71.02M31.72%-15.37M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+9.03%
Tesla
TSLA
+5.93%
Alphabet-A
GOOGL
+5.52%
Alphabet-C
GOOG
+5.46%
Coinbase
COIN
+3.77%

Unlock the Full List